deltatrials
Unknown NA NCT05008003

Vit D3 for Early Symptoms of COVID-19

Vit D3 Adjuvant Therapy for Early Mild Symptoms of COVID-19

Sponsor: Ayub Teaching Hospital

Conditions Covid19
Interventions Standard of care Vitamin D3
Updated 8 times since 2021 Last updated: Mar 22, 2022 Started: Sep 2, 2022 Primary completion: Mar 1, 2023 Completion: Apr 30, 2023

A NA clinical study on Covid19, this trial is ongoing. The trial is conducted by Ayub Teaching Hospital and has accumulated 8 data snapshots since 2022. Infectious disease trials contribute critical data for public health response and treatment development.

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  3. Apr 2024 — Jul 2024 [monthly]

    Unknown Status NA

    Status: Not Yet Recruiting → Unknown Status

  4. May 2022 — Apr 2024 [monthly]

    Not Yet Recruiting NA

    Status: Recruiting → Not Yet Recruiting

  5. Mar 2022 — May 2022 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

▶ Show 3 earlier versions

  1. Feb 2022 — Mar 2022 [monthly]

    Not Yet Recruiting NA

    Status: Recruiting → Not Yet Recruiting

  2. Oct 2021 — Feb 2022 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  3. Sep 2021 — Oct 2021 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ayub Teaching Hospital
  • Liaquat University of Medical & Health Sciences
Data source: Ayub Teaching Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Abbottabad, Pakistan